Compare Nephrocare Healt with Similar Stocks
Loading Valuation Snapshot...
Stock DNA
Healthcare Services
INR 5,383 Cr (Small Cap)
80.00
55
0.00%
-0.02
11.74%
9.18
Revenue and Profits:
Net Sales:
260 Cr
(Quarterly Results - Dec 2025)
Net Profit:
32 Cr
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.65%
0%
18.65%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Nephrocare Healt for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.52
Debt to EBITDA (avg)
4.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.83
Tax Ratio
23.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.40%
ROCE (avg)
4.47%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
80
Industry P/E
55
Price to Book Value
9.33
EV to EBIT
56.56
EV to EBITDA
31.96
EV to Capital Employed
9.47
EV to Sales
7.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.74%
ROE (Latest)
11.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 7 Schemes (3.1%)
FIIs
Held by 20 FIIs (9.3%)
Promoter with highest holding
Edoras Investment Holdings Pte Ltd (28.3%)
Highest Public shareholder
Investcorp India Investments Holding Limited (6.29%)
Individual Investors Holdings
5.92%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
160.66
155.92
3.04%
Operating Profit (PBDIT) excl Other Income
22.86
23.47
-2.60%
Interest
3.96
41.05
-90.35%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.45
-32.41
126.07%
Operating Profit Margin (Excl OI)
14.23%
15.05%
-0.82%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025
Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'25
Mar'25
Change(%)
Net Sales
543.60
NA
NA
Operating Profit (PBDIT) excl Other Income
94.89
NA
NA
Interest
14.30
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
34.24
NA
NA
Operating Profit Margin (Excl OI)
17.46%
NA%
NA
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
About Nephrocare Health Services Ltd 
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
No Details Available.
Company Coordinates 
No Company Details Available






